COMMUNIQUÉS West-GlobeNewswire

-
T1D Exchange Teams with Tidepool to Leverage Device Data for Groundbreaking Study of Type 1 Diabetes
29/11/2018 -
International Prix Galien Recognizes SPINRAZA® as Best Biotechnology Product
29/11/2018 -
MacroGenics and Zai Lab Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Margetuximab, MGD013 and TRIDENT™ Molecule in Greater China
29/11/2018 -
The Real Impact of PAD - Pluristem Therapeutics to Host Key Opinion Leader Meeting on Peripheral Artery Disease
29/11/2018 -
Loop Industries Establishes Multi-Year Supply Framework with the Coca-Cola Cross Enterprise Procurement Group
29/11/2018 -
Transactions under Novozymes’ stock buyback program
29/11/2018 -
Athenex Announces Licensing Agreement with PharmaEssentia for Rights to Oradoxel (Oral Docetaxel) in Certain Asian Territories
29/11/2018 -
Voyager Therapeutics Enters into Strategic Manufacturing Collaborations with Brammer Bio and Fujifilm Diosynth Biotechnologies
29/11/2018 -
Akcea Announces Upcoming Data Presentations at the 2018 American Society of Hematology Annual Meeting
29/11/2018 -
ISS Recommends that Keryx Biopharmaceuticals Stockholders Vote “FOR” the Proposed Merger with Akebia Therapeutics
29/11/2018 -
Antares Pharma Announces the Commercial Availability of XYOSTED™ (Testosterone Enanthate) Injection — A New Treatment for Adult Men Diagnosed With Testosterone Deficiency
29/11/2018 -
FDA Approves Firdapse® (amifampridine) for the Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS)
29/11/2018 -
US FDA approves Invivoscribe LeukoStrat CDx FLT3 Mutation Assay as CDx and Astellas drug XOSPATA (gilteritinib fumarate) for treatment of AML patients in the US
29/11/2018 -
Virginia Spine Institute Expands World-Class Surgical Team With Hiring of Spine Surgeon Ehsan Jazini, MD
29/11/2018 -
iKang Healthcare Group, Inc. Extends Shareholder Rights Plan
29/11/2018 -
Chi-Med Enters into Multiple Collaborations to Evaluate Combinations of Surufatinib and Fruquintinib with PD-1 Checkpoint Inhibitors
29/11/2018 -
LIDDS Delårsrapport juli - september 2018
29/11/2018 -
TRACON Pharmaceuticals and I-Mab Biopharma Announce Strategic Partnerships for Multiple Immuno-Oncology Programs
29/11/2018 -
Rule 2.9 Announcement
29/11/2018
Pages